Advancing Next Gen Antibodies and ADCs: From AI Driven Cell Line Development to Integrated Manufacturing
Antibody-drug conjugate (ADC) development continues to evolve, with increased molecular complexity leading to new opportunities and challenges across design, development, and manufacturing. The industry is advancing novel technologies to support...
